ONENA MEDICINES
Onena Medicines is a biotechnology company that creates innovative biological medicines to address the large unmet clinical need for breast cancer and other serious orphan illness.
ONENA MEDICINES
Social Links:
Industry:
Biotechnology Health Care Medical Device
Founded:
2019-01-01
Address:
Donostia-san Sebastiรกn, Pais Vasco, Spain
Country:
Spain
Website Url:
http://www.onenameds.com
Total Employee:
1+
Status:
Active
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Content Delivery Network Typekit Shutterstock Squarespace Squarespace Add To Cart
Similar Organizations
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
Insense
Insense is an innovative, biotechnology company with a proven track record in taking ideas from drawing board to market.
MedTech Flanders
MedTech Flanders is a network organization of Flemish medical device companies together with research partners, subcontractors.
NanoMedSyn
NanoMedSyn is a biotechnology company that provides a new generation of enzymes to treat lysosomal storage disorders.
Piramed
Piramed Limited, a biotech company, discovers and develops new medicines for the treatment of cancer and immune inflammatory disorders.
Current Employees Featured
Founder
Investors List
MassChallenge
MassChallenge investment in Non Equity Assistance - Onena Medicines
Official Site Inspections
http://www.onenameds.com
- Host name: 198.49.23.144
- IP address: 198.49.23.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013

More informations about "Onena Medicines"
onenameds.com
R & D Center. Onena Medicines S.L. Paseo Miramón, 170, planta 3, B06, 20014, Donostia, Gipuzkoa, SpainSee details»
Team โ Onena Medicines :: Cutting-edge AI โฆ
Team Right now, far too many patients are desperate for breakthrough treatments across different types of cancers and rare diseases. Onena Medicines rapidly discovers lifesaving drug treatments using artificial intelligence combined with โฆSee details»
Investor page โ Onena Medicines :: Cutting-edge AI technology โฆ
Contact us at any time. Neethan Amit Lobo (CEO) [email protected]. EU +34 680 810 350. US +1 415 501 0405See details»
Onena Medicines - Crunchbase Company Profile & Funding
Onena Medicines is a biotechnology company that creates innovative biological medicines to address the large unmet clinical need for breast cancer and other serious orphan illness.See details»
Onena Medicines Company Profile | Management and Employees โฆ
Www.onenameds.com Onena Medicines Profile and History Onena Medicines was founded by Drs. Neethan Lobo and Maider Zabala Ugalde, who are passionate cancer biology scientists โฆSee details»
Onena Medicines - LinkedIn
Onena Medicines is a biopharmaceutical company with a pipeline of first-in-class antibody medicines to treat recurrent and metastatic cancers and selected rare diseases.See details»
Onena Medicines - Overview, News & Similar companies - ZoomInfo
May 16, 2024 View Onena Medicines (www.onenameds.com) location in Basel-Landschaft, Switzerland , revenue, industry and description. Find related and similar companies as well as โฆSee details»
Onena Medicines - PitchBook
Onena Medicines General Information Description. Developer of an antibody drug discovery platform designed to reprogram cancer cells to treat advanced cancers to be centered around proprietary artificial intelligence.See details»
Onena Medicines - VentureRadar
Website: https://www.onenameds.com/ Develops innovative cancer therapies targeting drug-resistant cells by utilizing Dual SMAD Inhibiting Proteins (DSIPs) to prevent ...See details»
Onena Medicines - LinkedIn
Onena Medicines | 1189 seguidores en LinkedIn. AI-centric preclinical company discovering and developing novel biopharmaceuticals to treat cancer and rare diseases | Onena Medicines is a โฆSee details»
ONENA MEDICINES - ASEBIO
Development of anitbody-based medicines for patients with serious with unmet medical needs, such as cancer and rare pediatric diseases.See details»
Science and Technology - onenameds.com
Each cancer type (colorectal, breast, lung, etc.) secretes a unique DSIP profile. An anti-DSIP neutralizing antibody given to a cancer patient reprograms the cancer cells, resulting in the โฆSee details»
Onena Medicines AG at the Swiss Biotech Day
Onena Medicines is a biopharmaceutical company with a growing pipeline of first-in-class antibody medicines to treat advanced cancers. Onenaโs drugs neutralize a novel class of โฆSee details»
Onena Medicines - Products, Competitors, Financials, Employees ...
Onena Medicines Announces Appointment of Dr. Roland Kozlowski to the Board of Directors. Aug 27, 2024. News Provided By Share This Article Onena Medicines Logo Onena Medicines โฆSee details»
Onena Medicines - EU-Startups
Onena Medicines is a biopharmaceutical company with a pipeline of first-in-class antibody medicines to treat recurrent and metastatic cancers and selected rare diseases.See details»
Onena Medicines closes 3.7M CHF funding round to advance its โฆ
Oct 31, 2023 [email protected] SOURCE: Onena Medicines. Neethan Lobo Onena Medicines AG +1 415-501-0405 [email protected] Visit us on social media: LinkedIn. โฆSee details»
Onena Medicinesโ Post - LinkedIn
We are thrilled to announce our 3.7M CHF funding round for Onena Medicines AG, a BaseLaunch supported AI-driven cell reprogramming company aiming toโฆ | 11 comments on LinkedInSee details»
Onena Medicines Company Information - Funding, Investors, and โฆ
Https://onenameds.com. Dual SMAD Inhibiting Protein (DSIP) modulating antibody developer. GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY. OR โฆSee details»
Our Partners โ Onena Medicines :: Targeting locally secreted โฆ
© 2023 Onena Medicines. All rights reserved. DisclaimerSee details»
Pipeline โ Onena Medicines :: Targeting locally secreted growth โฆ
© 2023 Onena Medicines. All rights reserved. DisclaimerSee details»